Modifications of Microvascular EC Surface Modulate Phototoxicity of a Porphycene anti-ICAM-1 Immunoconjugate; Therapeutic Implications
Name
Edelman_Modifications of microvascular.pdf
Size
689.87 KB
Format
Adobe PDF
Checksum (MD5)
24a1bae96f7ce7c2d3f7708f8b3c3adb
Author(s)
Duran-Frigola, Miquel
Hernandez, Bryan
Nonell, Santi
Fosas, Elisabet
Santoma, Pablo
Llinas, Maria C.
Ruiz-Gonzalez, Ruben
Sanchez-Garcia, David
Balcells-Camps, Mercedes
Edelman, Elazer R
Date Issued
July 2013
Journal
Langmuir
Publisher
American Chemical Society (ACS)
Citation
Rosas, Elisabet, Pablo Santoma, Miquel Duran-Frigola, Bryan Hernandez, Maria C. Llinas, Ruben Ruiz-Gonzalez, Santi Nonell, David Sanchez-Garcia, Elazer R. Edelman, and Mercedes Balcells. “Modifications of Microvascular EC Surface Modulate Phototoxicity of a Porphycene Anti-ICAM-1 Immunoconjugate; Therapeutic Implications.” Langmuir 29, no. 31 (August 6, 2013): 9734–9743.
Version
Author's final manuscript
Abstract
Inflammation and shear stress can upregulate expression of cellular adhesion molecules in endothelial cells (EC). The modified EC surface becomes a mediating interface between the circulating blood elements and the endothelium, and grants opportunity for immunotherapy. In photodynamic therapy (PDT), immunotargeting might overcome the lack of selectivity of currently used sensitizers. In this study, we hypothesized that differential ICAM-1 expression modulates the effects of a drug targeted to surface ICAM-1. A novel porphycene–anti-ICAM-1 conjugate was synthesized and applied to treat endothelial cells from macro and microvasculature. Results show that the conjugate induces phototoxicity in inflamed, but not in healthy, microvascular EC. Conversely, macrovascular EC exhibited phototoxicity regardless of their state. These findings have two major implications; the relevance of ICAM-1 as a modulator of drug effects in microvasculature, and the potential of the porphycene bioconjugate as a promising novel PDT agent.
MIT Department
Massachusetts Institute of Technology. Institute for Medical Engineering & Science
Harvard University--MIT Division of Health Sciences and Technology
Terms of Use
Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use.
Persistent DSpace Link
DOI of Published Version
https://doi.org/10.1021/la401067d
